Seeking AlphaCrispr Therapeutics: Is There Something Else Behind The Potential Gilead Acquisition?Seeking Alpha8, 2018, we featured Crispr Therapeutics (NASDAQ:CRSP), a leading gene-editing innovator to service cancers and rare genetic diseases, in the… Continue reading
Sci-News.comResearchers Create Functioning Human Kidney Tissue Using Stem CellsSci-News.comKidney glomeruli (constituent parts of the organ) were generated from human pluripotent stem cells grown in laboratory culture dishes. They were combined with a … Continue reading
The Atlantic |
Can This Company Convince You to Love GMOs?
The Atlantic The other founder was Tom Knight, a former MIT professor best known as the godfather of synthetic biology. From the start in 2009, Ginkgo’s team knew they wanted to make it easier to tinker with the DNA in yeast and bacteria. The basic technology has … |
Yale News |
Researchers develop novel immunotherapy to target colorectal cancer
Yale News Certain cancers fail to respond to existing immunotherapy drugs that are designed to unleash the body’s immune system against tumors. To investigate alternative approaches to these cancers, the Yale-led team focused on a protein molecule, DKK2, an … |
|
A clinical trial to test a gene therapy treatment for a rare liver disease
EurekAlert (press release) The technology used in the trial was developed by the ‘Immunology and Gene Therapy for Liver Disease’ team at Généthon, headed by Dr Federico Mingozzi. In partnership with research teams in Italy and the Netherlands, Généthon has developed an Adeno … |